Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.
about
Emerging Therapies for OsteoporosisFolic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolismTransforming growth factor β1 inhibition protects from noise-induced hearing loss.C-Raf deficiency leads to hearing loss and increased noise susceptibility.Long-Term Dietary Folate Deficiency Accelerates Progressive Hearing Loss on CBA/Ca Mice.Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.Bone Status in a Patient with Insulin-Like Growth Factor-1 Receptor Deletion Syndrome: Bone Quality and Structure Evaluation Using Dual-Energy X-Ray Absorptiometry, Peripheral Quantitative Computed Tomography, and Quantitative Ultrasonography.PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei.The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss.Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats.
P2860
Q26782109-E85A8FD0-991D-4DED-92BF-BB54EA686FB4Q27319467-38286CA3-A974-4864-8AB0-8661816B34C4Q30414703-BC911524-0AA1-404B-9427-B232FFFE503EQ30664961-E6CE9A9F-CC6E-4179-BA18-F71E5F986762Q37221719-5B46A1B4-0BFA-49C9-B8AC-DBBB96DA0F67Q38563889-51B37611-A01A-4924-BB4C-FE613A9D3780Q41238081-F34329BF-45AD-49FC-B6E5-30BAF116DCA1Q48038374-BEA579D3-FFEB-40A4-BBCA-13A1D3713D46Q48462977-34293EA3-28C1-4D01-9A2F-01833B01DFEAQ49246728-87E0DD5E-9CB2-435A-9393-FBAD5E750ECDQ50244063-2867A7EE-2194-48DD-810F-BF6B921FE711
P2860
Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@ast
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@en
type
label
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@ast
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@en
prefLabel
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@ast
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@en
P2093
P2860
P50
P1433
P1476
Treatment with N- and C-termin ...... ities in IGF-I deficient mice.
@en
P2093
Ana López-Herradón
Pedro Esbrit
Rafael Cediel
Silvia Murillo-Cuesta
P2860
P304
P356
10.1371/JOURNAL.PONE.0087536
P407
P577
2014-02-04T00:00:00Z